Pharmacogenetics News and Research

RSS
The terms pharmacogenomics and pharmacogenetics are often used interchangeably to describe a field of research focused on how genes affect individual responses to medicines. Whether a medicine works well for you—or whether it causes serious side effects—depends, to a certain extent, on your genes.

Just as genes contribute to whether you will be tall or short, black-haired or blond, your genes also determine how you will respond to medicines. Genes are like recipes—they carry instructions for making protein molecules. As medicines travel through your body, they interact with thousands of proteins. Small differences in the composition or quantities of these molecules can affect how medicines do their jobs.

These differences can be due to diet, level of activity, or the medicines a person takes, but they can also be due to differences in genes. By understanding the genetic basis of drug responses, scientists hope to enable doctors to prescribe the drugs and doses best suited for each individual.
Foundation for nationwide consensus on access to genetic information

Foundation for nationwide consensus on access to genetic information

AssureRx closes $11 million Series B financing

AssureRx closes $11 million Series B financing

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

IBM announces new Patient Empowerment System

IBM announces new Patient Empowerment System

Experts caution against dangers of inflated expectations of genomic medicine

Experts caution against dangers of inflated expectations of genomic medicine

Takeda, Zinfandel enter global licensing agreement for TOMM40 biomarker assay for Alzheimer's disease

Takeda, Zinfandel enter global licensing agreement for TOMM40 biomarker assay for Alzheimer's disease

AutoGenomics introduces first automated molecular assay for Familial Mediterranean Fever

AutoGenomics introduces first automated molecular assay for Familial Mediterranean Fever

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Quintiles, London Genetics enter strategic alliance to offer pharmacogenetics solutions for personalized medicine

Quintiles, London Genetics enter strategic alliance to offer pharmacogenetics solutions for personalized medicine

Racial disparities in risk and survival among children with neuroblastoma: Study

Racial disparities in risk and survival among children with neuroblastoma: Study

New pharmacogenetic test enables a personalized medicine approach

New pharmacogenetic test enables a personalized medicine approach

Astrimmune, London Genetics enter collaboration to plan biomarker identification program

Astrimmune, London Genetics enter collaboration to plan biomarker identification program

NEWMEDS launches largest database to advance drug development for depressio, schizophrenia

NEWMEDS launches largest database to advance drug development for depressio, schizophrenia

AutoGenomics granted FDA 510(k) clearance for INFINITI CYP2C19 Assay

AutoGenomics granted FDA 510(k) clearance for INFINITI CYP2C19 Assay

2010 AAO-MEACO meeting focuses on genetic medicine

2010 AAO-MEACO meeting focuses on genetic medicine

Commercial genetic profiling services should provide detailed information about test results: Report

Commercial genetic profiling services should provide detailed information about test results: Report

NIH to award $64M under Transformative Research Projects program

NIH to award $64M under Transformative Research Projects program

Boehringer Ingelheim, Eurofins Medigenomix partner in DNA banking and pharmacogenetics, pharmacogenomics

Boehringer Ingelheim, Eurofins Medigenomix partner in DNA banking and pharmacogenetics, pharmacogenomics

Researchers to develop vaginal microbicide gels to reduce HIV risk

Researchers to develop vaginal microbicide gels to reduce HIV risk

Diaceutics, London Genetics partner to develop software decision tools for biomarker research

Diaceutics, London Genetics partner to develop software decision tools for biomarker research